• Nutraceutical (Longevinex®) Reduces Time It Takes Older Eyes To Adapt To The Dark; Family Members Of Patients With Macular Degeneration Urged To Undergo Dark Adaptation Test

    Could Detect/Halt Vision Loss Up To 4 Years Before It Occurs

    For the first time eye researchers have been able to reduce the time it takes for older eyes to adapt to the dark with use of an oral nutraceutical (Longevinex®). Prolonged dark adaptation time is a marker of the future onset of a dreaded vision problem – macular degeneration.

    Twelve of the first fourteen consecutive eyes tested improved or were unexpectedly stable after a dark adaptation test was administered among senior adults with pre-existing visual loss taking a selected daily oral nutraceutical. While only a small number of eyes were tested the effect was statistically so demonstrable there is only ~1% probability the results obtained from this intervention were obtained by chance (p value 0.01). [Statistics How To]

    Dr. Stuart Richer OD, PhD, Director, Ocular Preventive Medicine at the Captain James A Lovell Federal Health Care Facility, North Chicago, IL, and President of the Ocular Nutrition Society, announced the discovery at the annual meeting of the Association for Research in Vision & Ophthalmology (ARVO), Baltimore, MD, May 8, 2017.

    Read Report

  • STUART RICHER and the LAST Team Has clinically proven the benefits of nutritional supplements to prevent and even cure age-related vision loss.

    Eat your spinach. Most kids probably heard that a million times when they were growing up. Well, new research suggests that it’s payback time. Rather than parents telling children they need to eat their spinach, children should be saying this same thing to their parents and grandparents. Why? According to the aforementioned research, spinach contains a nutrient called lutein that can not only help prevent, but can actually reverse age-related vision loss, a discovery that could have a dramatic impact on the lives of millions of Americans.

    Most people would assume that a finding of this magnitude must have been uncovered by the National Institutes of Health or one of the country’s leading universities. Most people would be wrong. This discovery was made, not at one of the nation’s most famous research facilities, but at the Department of Veteran Affairs (VA) hospital in North Chicago by Dr. Stuart Richer and his team of eye and health specialists.

    Read Report

  • THE MACULAR DEGENERATION DIET & PREVENTION PLAN

    Read Report

  • Calcium supplements may increase risk for AMD

    A recent study revealed that supplementary calcium consumption is associated with the development of age-related macular degeneration (AMD).

    “Optometrists should be fully engaged in identifying over-calcified patients.”

    The findings suggest that people who consume more than 800 mg per day of supplementary calcium are 85 percent more likely to be diagnosed with AMD than those who do not supplement with calcium. The association between supplementary calcium and AMD was found to be stronger in older individuals, which is due to the longer duration of calcium supplementation.

    Read Report

  • First Report Of Internally-Derived Stem-Cell Survival To Regenerate Damaged Cells In The Human Retina Using Molecular Medicine

    North Chicago, IL (December 31, 2012) – The first report using molecular medicine to regenerate damaged tissues in the back of the human eye via use of small antioxidant molecules to promote survival of internally-produced stem cells is being reported today. It may be the first successful report of cellular or tissue regeneration via internally-derived stem cells in all of medicine.

    In a newly published scientific book (Advancing Medicine With Food & Nutrients, 2nd edition, CRC Press (Ingrid Kohlstadt, editor), Dec 2012), Dr. Stuart Richer, OD, PhD, Director, Ocular Preventive Medicine- Eye Clinic at the James A Lovell Federal (Veterans) Health Care Center in North Chicago, presents striking photographic evidence of stem cell regeneration of damaged tissues at the back of the eye of a patient with dry macular degeneration accompanied by restoration of vision after using a nutriceutical comprised of small natural antioxidant molecules.

    Read Report

  • First Oral Agent To Quell Invasive Macular Degeneration, Restore Lost Vision In Otherwise Hopeless Cases

    From: The Association for Research in Vision & Ophthalmology (ARVO) annual meeting, Fort Lauderdale, Fla.,

    Ft. Lauderdale, FL (May 6, 2012) – There may be new found hope for patients whose vision is threatened when medicine injected directly into the eyes fails to cause abnormal blood vessels to recede. While injectable drugs called angiogenesis (an-gee-oh-jen-esis) inhibitors are considered a modern miracle and have become the standard of care for patients with the fast-progressive form of macular degeneration, they are not foolproof. For the first time researchers report that an oral nutriceutical, used on a last-resort clinical basis, rapidly restores vision to otherwise hopeless patients who face permanent loss.

    Read Report